|
Type of Disease |
Treatment |
|
Well differentiated Tumours |
Variety of biotherapeutic regimens (eg. Octreotide, lanreotide± IFN α) |
|
Poorly Differentiated Tumours |
Chemotherapy |
|
Primary Tumours
- Duodenal tumour <1cm
- Duodenal tumour ≥2cm
- Jejunal/ileal tumour >2cm/multiple
- Appendiceal tumour <1cm
- 1-2cm appendiceal tumour without evidence of local invasion, or tumour at base of appendix
- Appendiceal tumour >2cm; Cecal involvement
- Rectal tumour <1cm
- Rectal tumour 1-2cm
|
Definitive treatment with surgical resection
- Local excision
- Pancreatoduodenectomy or segmental resection
- Wide excision of bowel and adjacent mesentery (Distal ileocolectomy to adequately remove lymphatic drainage)
- Careful search for 2nd primaries/multiple tumours, metastatic liver disease
- Wide resection, excising all areas of lymph node drainage
- Appendectomy
- Appendectomy
- Anterior resection +/- colostomy
- Biopsy & if muscular invasion APR/LAR
- Complete transanal excision, regularproctoscopic examinations
- Low anterialrection / abdominoperineal resection
|
|
Presence of Distant Metastasis
- Single liver metastases
- Multiple liver metastases
|
- Surgery
- Medical treatment +/- Surgical debulkment
- Hepactectomy
- Hepactectomy to debulk
- Somatostatin analogue prior to hepatic artery embolisation/ligation ± 5FU to prevent carcinoid crisis
- Systematic chemotherapy
|